- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Face-to-face consultations
- Phone consultations
- Video consultations
Last updated: 8 Jun 2020
Mr Daniel Cohen is a Consultant Urological Surgeon at Royal Free London NHS Foundation Trust.
He completed his surgical training in London before undertaking a post-CCT Fellowship in HoLEP and stone surgery. He was awarded a PhD from Imperial College London for his research in healthcare education and health policy. Mr Cohen is one of two UK panel members on the European Association of Urology Bladder Cancer Guidelines Panel.
Mr Cohen has a broad general urology practice with special interests in prostate and bladder conditions, including benign prostatic disease, including Holmium Laser Surgery (HoLEP), raised PSA, prostate cancer diagnosis using MRI and transperineal biopsy, bladder cancer and bladder problems including infections, blood in the urine and incontinence. He is a core member of the bladder cancer and prostate cancer multi-disciplinary teams at the Royal Free London NHS Foundation Trust.
Mr Cohen maintains an active research interest. He has co-authored over 20 peer-reviewed papers and has presented his research in Europe and the United States.
Areas of interest
Raised PSA, prostate cancer,
Haematuria, blood in urine, bladder cancer, urinary incontinence, benign prostate enlargement, lower urinary tract symptoms, testicular lumps, Laser prostate surgery
- To Pay Your Outstanding Balance, Please Call
- 01702 382362
Current NHS consultant posts held
Consultant Urological Surgeon at Royal Free London NHS Foundation Trust
Distinction award - Association of Surgical Education, United States
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D et al. Eur Urol. 2020 Jun 24;S0302-2838(20)30427-9. doi: 10.1016/j.eururo.2020.05.042.
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel. Soukup V, Čapoun O, Cohen D, Hernández V, et al. Eur Urol Focus 2020 May 15;6:479-489
Papillary Urothelial Neoplasm of Low Malignant Potential (PUN-LMP): Still a Meaningful Histo-Pathological Grade Category for Ta, Noninvasive Bladder Tumors in 2019? Hentschel A, Van Rhijn BW,,Cohen D et al Urol Oncol 2020 May;38(5):440-448. doi: 10.1016/j.urolonc.2019.10.002. Epub 2019 Nov 5.
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V. European Urology Nov 2019;76:5
Validation of behavioural simulations: a case study on enhancing collaboration between partnership organizations. Cohen D, Vlaev I, Heitmueller A, Parston G, Schmidtke K Darzi A. J Public Health (Berl.) 2018 https://doi.org/10.1007/s10389-018-0948-y
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered? Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V; European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer. Eur Urol Focus. 2018 Jul;4(4):525-528. doi: 10.1016/j.euf.2018.07.023. Epub 2018 Jul 27.
- FRCS (Urol) Royal College of Surgeons (England) 2016
- PhD Imperial College London 2015
Reference number 6102782
Details of entry to specialist register
- Urology, 2017
Affiliations / memberships
British Association of Urological Surgeons
European Association of Urology
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.